The loss of caveolin-1 expression in a knock-in mouse model of Huntington’s disease suppresses the pathophysiology in vivo—a protective effect that might also be related to a decrease in the OCTN2 plasma membrane expression [23]. The gene discussed is SLC22A5; the disease is juvenile Huntington disease.